Disseminated herpes zoster in an immune‐competent patient after SARS‐CoV‐2 vaccine (BNT162b2 Comirnaty, Pfizer). (26th April 2022) - Zengarini, C.; Misciali, C.; Ferrari, T.; Dika, E.; La Placa, M.; Piraccini, B.M.; Baraldi, C.